BioDrugs

, Volume 20, Issue 2, pp 121–135

Peroxisome Proliferator-Activated Receptor-γ

Novel Therapeutic Target Linking Adiposity, Insulin Resistance, and Atherosclerosis
Mechanisms and Targets

DOI: 10.2165/00063030-200620020-00006

Cite this article as:
Kepez, A., Oto, A. & Dagdelen, S. BioDrugs (2006) 20: 121. doi:10.2165/00063030-200620020-00006
  • 38 Views

Abstract

Insulin resistance and obesity is a common health problem in the industrialized world. As a result of the availability of high-calorie food and a reduction in energy expenditure, maladaptive metabolic processes may interfere with the action of insulin and increase susceptibility for the development of atherosclerotic cardiovascular diseases. With the advent of peroxisome proliferator-activated receptors (PPARs), the mechanisms of this maladaptation and its relationship to insulin resistance syndrome components have become less obscure, promising new therapeutic approaches for this common problem. In this review we first focus on the molecular structure and cellular mechanisms of action of these receptors and then discuss how PPAR-γ, a PPAR isoform, provides a link between adiposity, insulin resistance, and atherosclerosis.

Copyright information

© Adis Data Information BV 2006

Authors and Affiliations

  1. 1.Faculty of Medicine Cardiology DepartmentHacettepe UniversityAnkaraTurkey
  2. 2.Endocrinology DepartmentHacettepe University Faculty of MedicineAnkaraTurkey